WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience The New Axio Examiner
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wong, L. A.
Right arrow Articles by Watkins, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wong, L. A.
Right arrow Articles by Watkins, J. C.

 Previous Article  |  Next Article 

Journal of Neuroscience, Vol 14, 3881-3897, Copyright © 1994 by Society for Neuroscience


ARTICLE

Willardiines differentiate agonist binding sites for kainate- versus AMPA-preferring glutamate receptors in DRG and hippocampal neurons

LA Wong, ML Mayer, DE Jane and JC Watkins
Laboratory of Cellular and Molecular Neurophysiology, NICHD, National Institutes of Health, Bethesda, Maryland 20892.

Concentration jump responses to 5-substituted (S)-willardiines were recorded from dorsal root ganglion (DRG) and hippocampal neurons under voltage clamp. After block of desensitization by concanavalin-A, dose- response analysis for activation of kainate-preferring receptors in DRG neurons gave the potency sequence trifluoromethyl > iodo > bromo approximately chloro > nitro approximately cyano > kainate > methyl > fluoro > (R,S)-AMPA >> willardiine; EC50 values for the most and least potent willardiine derivatives, 5-trifluoromethyl (70 nM) and 5-fluoro (69 microM), differed 1000-fold. The potency sequence for equilibrium responses at AMPA-preferring receptors in hippocampal neurons was strikingly different from that obtained in DRG neurons: fluoro > cyano approximately trifluoromethyl approximately nitro > chloro approximately bromo > (R,S)-AMPA > iodo > willardiine > kainate > methyl. In hippocampal neurons EC50 values for the most and least potent willardiine derivatives, 5-fluoro (1.5 microM) and 5-methyl (251 microM), differed only 170-fold. Consistent with equilibrium potency measurements, in DRG neurons the kinetics of deactivation for willardiines, recorded following a return to agonist-free solution, were rapid for 5-fluoro (tau off = 43 msec) but slow for 5-iodo (tau off = 4.2 sec), while the opposite sequence was observed for hippocampal neurons, slow for 5-fluoro (tau off = 2.1 sec) and rapid for 5-iodo (tau off = 188 msec). The kinetics of recovery from desensitization showed comparable agonist- and cell-dependent differences. Structure-activity analysis for agonist responses recorded from DRG and hippocampal neurons suggests that for both kainate- preferring and AMPA-preferring receptors the binding of willardiines involves interactions with polar groups such that potency is related to ionization of the uracil ring, and hence the electron-withdrawing ability of the 5-position substituent. However, kainate-preferring receptors differ from AMPA-preferring receptors in possessing a lipophilic pocket that further enhances agonist potency by hydrophobic bonding of the 5-substituent. In contrast, AMPA-preferring receptors lack such a lipophilic site, and for 5-position substituents of the same electron-withdrawing ability, potency decreases with increase in size.


This article has been cited by other articles:


Home page
J. Physiol.Home page
M. F. Ireland, F. C. Lenal, A. R. Lorier, D. E. Loomes, T. Adachi, T. S. Alvares, J. J. Greer, and G. D. Funk
Distinct receptors underlie glutamatergic signalling in inspiratory rhythm-generating networks and motor output pathways in neonatal rat
J. Physiol., May 1, 2008; 586(9): 2357 - 2370.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. M. Nielsen, T. Liljefors, P. Krogsgaard-Larsen, and J. Egebjerg
The Selective Activation of the Glutamate Receptor GluR5 by ATPA Is Controlled by Serine 741
Mol. Pharmacol., January 1, 2003; 63(1): 19 - 25.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
J. Lerma, A. V. Paternain, A. Rodriguez-Moreno, and J. C. Lopez-Garcia
Molecular Physiology of Kainate Receptors
Physiol Rev, July 1, 2001; 81(3): 971 - 998.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. Cui and M. L. Mayer
Heteromeric Kainate Receptors Formed by the Coassembly of GluR5, GluR6, and GluR7
J. Neurosci., October 1, 1999; 19(19): 8281 - 8291.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
R. Dingledine, K. Borges, D. Bowie, and S. F. Traynelis
The Glutamate Receptor Ion Channels
Pharmacol. Rev., March 1, 1999; 51(1): 7 - 62.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
G. T. Swanson, T. Green, and S. F. Heinemann
Kainate Receptors Exhibit Differential Sensitivities to (S)-5-Iodowillardiine
Mol. Pharmacol., May 1, 1998; 53(5): 942 - 949.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
T. J. Wilding and J. E. Huettner
Activation and Desensitization of Hippocampal Kainate Receptors
J. Neurosci., April 15, 1997; 17(8): 2713 - 2721.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L.-M. Zhou, Z.-Q. Gu, A. M. Costa, K. A. Yamada, P. E. Mansson, T. Giordano, P. Skolnick, and K. A. Jones
(2S,4R)-4-Methylglutamic Acid (SYM 2081): A Selective, High-Affinity Ligand for Kainate Receptors
J. Pharmacol. Exp. Ther., January 1, 1997; 280(1): 422 - 427.
[Abstract] [Full Text]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2008 by Society for Neuroscience ONLINE ISSN: 1529-2401
-